TEL AVIV, Israel--(BUSINESS WIRE)--RedHill Biopharma Ltd., an Israeli biopharmaceutical company, announced today the successful completion of the Company’s initial public offering (IPO), of shares and warrants, on the Tel-Aviv Stock Exchange (TASE). The Company raised NIS 51.6 million (approximately $13.6 million).
